Half Year 2026 IMCD NV Earnings Call Transcript
Key Points
- IMCD NV (IMCDY) reported a strong first half of 2026 with gross profit up 7% and EBITA up 8% on a constant currency basis, driven by organic growth and acquisitions.
- The company achieved a robust cash conversion margin of 76.2% and increased free cash flow to EUR222 million, reflecting disciplined working capital management.
- EMEA region performed exceptionally well, with organic EBITA growth of 7% in the first half and a strong 20% in Q2, supported by supplier wins and stable demand.
- IMCD NV (IMCDY) successfully completed three strategic acquisitions in South Korea, UK/Ireland, and Thailand, strengthening its positions in beauty, nutrition, and plastics.
- The company maintained strict cost control, with no organic increase in costs year-over-year, while investing in sales teams and digital tools to enhance commercial activity.
- A promising start to Q3 2026 was noted, with stable demand trends and no significant pre-buying, indicating sustained momentum.
- IMCD NV (IMCDY) saw positive developments in innovation and lab activity, with strong project pipelines converting into gross profit growth.
- Gross profit margin decreased by 0.7 percentage points to 24.9%, primarily due to lower-margin acquisitions and product mix changes.
- Americas segment reported negative organic growth in the first half, with a weak coatings and construction market and delayed pricing tailwinds impacting performance.
- Currency headwinds negatively impacted EBITA by EUR12 million (minus 4%) in the first half, affecting translation of local currencies into euros.
- The M&A pipeline remains active but discussions are taking longer due to dynamic market conditions, with only EUR50 million spent on acquisitions in H1, the lowest since 2020.
- Working capital days increased to 70 from 69 year-over-year, driven by higher debtor days due to strong Q2 sales, though inventory levels remain elevated to meet demand.
- Pricing tailwinds were concentrated in the semi-specialty portfolio, with larger specialty components seeing only low single-digit increases, limiting overall margin expansion.
Hello, and welcome to IMCD's 2026 half-year results conference call hosted by Marcus Jordan, CEO, and Hans Kooijmans, CFO. (Operator Instructions)
I would now like to give the floor to Marcus Jordan. Mr. Jordan, please go ahead.
Thank you very much, [Elba]. Good morning to you all, and a warm welcome. I'm Marcus Jordan, and I'm here today with our CFO, Hans Kooijmans, for the 2026 half-year results, which we published in a press release earlier this morning. We had a positive first half of the year with both gross profit and EBITA organic growth and a strong cash conversion.
When looking at the overall business during the first half of the year, I'm proud of how our teams navigated the dynamic environment, which included the majority of our suppliers implementing price increases. The magnitude of these price increases varied significantly, with the larger specialty part of the portfolio generally receiving much lower percentage increases and showing less
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
